Form 4: Astrana Health CEO Brandon Sim Reports Share Surrender for Tax Obligations and Updates on Restricted Stock Vesting
SEC Form 4
Astrana Health's CEO, Brandon Sim, surrendered shares to cover tax obligations related to vested restricted stock and provided updates on his holdings, including shares held in irrevocable trusts and the vesting schedule of restricted stock units.
Summary
- On March 29, 2024, Brandon Sim, CEO and President of Astrana Health, surrendered 37,957 shares of common stock to cover tax withholding obligations at a price of $41.99 per share.
- Following the transaction, Sim directly owns 950,968 shares.
- Sim also indirectly owns 258,824 shares through the Sim Family Irrevocable Trust 2021 and 392,816 shares through the Brandon Sim 2020 Irrevocable Trust.
- The direct holdings include 559,168 shares of unvested restricted stock that will vest over time, subject to continuous employment.
- Additionally, Sim holds 86,305 restricted stock units that will vest in semi-annual installments beginning on October 2, 2024.
- The reported transactions do not constitute an admission of beneficial ownership for purposes of Section 16 or any other purpose, except to the extent of his pecuniary interest.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing, so the sentiment is neutral. However, the vesting of restricted stock units is a positive sign for long-term alignment of management and shareholder interests.
Positives
- The report provides transparency regarding the CEO's stock ownership and vesting schedule.
- The vesting of restricted stock units incentivizes the CEO to remain with the company.
Future Outlook
The document outlines the vesting schedule for restricted stock and restricted stock units, indicating future equity-based compensation for the CEO contingent on continued employment and, in some cases, achievement of performance goals.
Management Comments
- The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Comparison to Industry Standards
- Vesting schedules for restricted stock and restricted stock units are common compensation practices in publicly traded companies to align management's interests with those of shareholders.
- The specific vesting terms (e.g., annual or semi-annual installments, performance-based vesting) vary across companies and industries.
Stakeholder Impact
- Shareholders are informed about the CEO's equity holdings and incentives.
- Employees may be indirectly impacted by the CEO's incentives to improve company performance.
Key Dates
| Date | Description |
|---|---|
| 03/29/2024 | Date of share surrender for tax obligations. |
| 04/02/2024 | Date of grant of 86,305 restricted stock units (previously disclosed). |
| 04/04/2024 | Date of Form 4 filing disclosing the grant of restricted stock units. |
| 04/19/2024 | Date of signature on this Form 4. |
| 06/27/2024 | First vesting date for some restricted stock shares. |
| 09/30/2024 | First vesting date for some restricted stock shares. |
| 10/02/2024 | First vesting date for restricted stock units. |
| 11/02/2024 | Vesting date for 14,151 shares of restricted stock. |
| 06/27/2025 | Second vesting date for some restricted stock shares. |
| 06/27/2026 | Third vesting date for some restricted stock shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.